Clinical Trials Browser

Carcinoma × Sunitinib × Genitourinary × Clear all

NCT05043090 2026-05-22

SAMETA

Phase 3 Active not recruiting

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT03091192 2026-04-14

Savolitinib vs. Sunitinib in MET-driven PRCC.

Phase 3 Active not recruiting

60 enrolled 15 charts

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

NCT01216371 2012-02-13

SMAT

Phase 2 Unknown

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis